Article info
PDFExtended reports
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
- Correspondence to:
Dr A Kavanaugh
Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0943, USA; akavanaughucsd.edu
Citation
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Publication history
- Accepted January 16, 2005
- First published January 27, 2005.
Online issue publication
April 10, 2023
Article Versions
- Previous version (9 January 2022).
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases